Medline reported cash from operations of $715.00M and free cash flow of $604.00M for the quarter ended Jun 2026. This cash flow statement covers 4 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2025 | Jun2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 322.00M | 333.00M | 239.00M | 139.00M |
| Share-based CompensationStock Comp. | 28.00M | 15.00M | 23.00M | 274.00M |
| Deferred Taxes | -4.00M | -3.00M | 37.00M | 64.00M |
| Asset Writedowns and ImpairmentWritedown | 26.00M | 13.00M | 1.00M | 6.00M |
| Cash from OperationsCash from Ops. | 682.00M | 197.00M | 412.00M | 715.00M |
| Depreciation, Depletion & Amortization | ||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 15.00M | 15.00M | 11.00M | 13.00M |
| Depreciation & Amortization (CF)Dep. & Amort. | 247.00M | 250.00M | 254.00M | 256.00M |
| Change in Working Capital | ||||
| Change in ReceivablesChange Receivables | 98.00M | 51.00M | 146.00M | 2.00M |
| Change in InventoryChange Inventory | -71.00M | 231.00M | 42.00M | 74.00M |
| Change in Account PayablesChange Payables | 35.00M | 10.00M | 6.00M | 83.00M |
| Change in Accured ExpensesChange Accured Exp. | 34.00M | -208.00M | 72.00M | 119.00M |
| Investing Activities | ||||
| Capital ExpendituresCapex | 98.00M | 110.00M | 96.00M | 111.00M |
| Acquisitions | -6.00M | |||
| Cash from Investing ActivitiesCash from Investing | -92.00M | -143.00M | -96.00M | -461.00M |
| Financing Activities | ||||
| Cash from Financing ActivitiesCash from Financing | -9.00M | -328.00M | -13.00M | -159.00M |
| Dividend Payments | ||||
| Dividends Paid - CommonDiv. Paid (Common) | 303.00M | 10.00M | 113.00M | |
| Additional items | ||||
| Exchange Rate EffectFX Effect | 9.00M | 18.00M | -7.00M | -4.00M |
| Change in Cash | 590.00M | -256.00M | 296.00M | 91.00M |
| Free Cash FlowFCF | 584.00M | 87.00M | 316.00M | 604.00M |
| Net Cash FlowNCF | 581.00M | -274.00M | 303.00M | 95.00M |